Guggenheim Maintains Buy on IDEAYA Biosciences, Lowers Price Target to $52
Benzinga Newsdesk 4 hours ago
Analyst RatingsNewsPrice Target
Guggenheim analyst Paul Jeng maintains IDEAYA Biosciences (NASDAQ:IDYA) with a Buy and lowers the price target from $57 to $52.
Guggenheim analyst Paul Jeng maintains IDEAYA Biosciences (NASDAQ:IDYA) with a Buy and lowers the price target from $57 to $52.